These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 15221934

  • 1. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
    Rakha EA, Pinder SE, Paish EC, Robertson JF, Ellis IO.
    J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
    [Abstract] [Full Text] [Related]

  • 2. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.
    Zacharatos P, Kotsinas A, Evangelou K, Karakaidos P, Vassiliou LV, Rezaei N, Kyroudi A, Kittas C, Patsouris E, Papavassiliou AG, Gorgoulis VG.
    J Pathol; 2004 Jul; 203(3):744-53. PubMed ID: 15221933
    [Abstract] [Full Text] [Related]

  • 3. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
    Pellikainen J, Kataja V, Ropponen K, Kellokoski J, Pietiläinen T, Böhm J, Eskelinen M, Kosma VM.
    Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
    [Abstract] [Full Text] [Related]

  • 4. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY, Liu SC, Al-Saleem LF, Holloran D, Babb J, Guo X, Klein-Szanto AJ.
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [Abstract] [Full Text] [Related]

  • 5. Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.
    Rakha EA, Pinder SE, Paish CE, Ellis IO.
    Br J Cancer; 2004 Oct 18; 91(8):1591-6. PubMed ID: 15354217
    [Abstract] [Full Text] [Related]

  • 6. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus.
    Yamazaki K, Hasegawa M, Ohoka I, Hanami K, Asoh A, Nagao T, Sugano I, Ishida Y.
    J Clin Pathol; 2005 Sep 18; 58(9):904-10. PubMed ID: 16126868
    [Abstract] [Full Text] [Related]

  • 7. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO.
    Histopathology; 2005 Jun 18; 46(6):685-93. PubMed ID: 15910600
    [Abstract] [Full Text] [Related]

  • 8. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A.
    BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120
    [Abstract] [Full Text] [Related]

  • 9. Expression of p53 protein has no independent prognostic value in breast cancer.
    Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjänen K.
    J Pathol; 1995 Nov 10; 177(3):225-32. PubMed ID: 8551383
    [Abstract] [Full Text] [Related]

  • 10. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, Bektas N, Dürst M, Kristiansen G, Wild PJ, Hartmann A, Knuechel R, Dahl E.
    Oncogene; 2008 Jan 31; 27(6):865-76. PubMed ID: 17653090
    [Abstract] [Full Text] [Related]

  • 11. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
    Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bànkfalvi A, Kneif S, Torhorst J, Zuber M, Köchli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F, Boecker W.
    J Pathol; 2002 Oct 31; 198(2):181-9. PubMed ID: 12237877
    [Abstract] [Full Text] [Related]

  • 12. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.
    J Pathol; 2006 Mar 31; 208(4):495-506. PubMed ID: 16429394
    [Abstract] [Full Text] [Related]

  • 13. Loss of CD59 expression in breast tumours correlates with poor survival.
    Madjd Z, Pinder SE, Paish C, Ellis IO, Carmichael J, Durrant LG.
    J Pathol; 2003 Aug 31; 200(5):633-9. PubMed ID: 12898600
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM.
    Clin Cancer Res; 2004 Nov 15; 10(22):7621-8. PubMed ID: 15569994
    [Abstract] [Full Text] [Related]

  • 15. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.
    Breast Cancer Res Treat; 2006 Jun 15; 97(3):275-83. PubMed ID: 16344916
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
    Gong YP, Yarrow PM, Carmalt HL, Kwun SY, Kennedy CW, Lin BP, Xing PX, Gillett DJ.
    Eur J Surg Oncol; 2007 May 15; 33(4):438-43. PubMed ID: 17125961
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Nguyen TV, Bova RJ, Kench JG, Cole IE, Musgrove EA, Henshall SM, Sutherland RL.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3705-11. PubMed ID: 14506162
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
    Charpin C, Garcia S, Bonnier P, Martini F, Andrac L, Horschowski N, Lavaut MN, Allasia C.
    J Pathol; 1998 Apr 01; 184(4):401-7. PubMed ID: 9664906
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q, Yoshimura G, Suzuma T, Tamaki T, Umemura T, Nakamura M, Nakamura Y, Wang X, Mori I, Sakurai T, Kakudo K.
    Clin Cancer Res; 2001 Dec 01; 7(12):3869-73. PubMed ID: 11751477
    [Abstract] [Full Text] [Related]

  • 20. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
    Anticancer Res; 2004 Dec 01; 24(4):2391-400. PubMed ID: 15330189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.